Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Atlantic American | AAME | Nov 22, 2024 | 1.64 | +0.61 |
Atlantic Coastal Acquisition II A | ACAB | Nov 22, 2024 | 5.77 | 0.00 |
Atlantic Union Bank | AUB | Nov 22, 2024 | 42.63 | +1.77 |
Atlantic Union Bankshares A Pref | AUB-A | Nov 22, 2024 | 24.95 | -0.20 |
Atlantica Sustainable Infrastructure | AY | Nov 22, 2024 | 22.13 | -0.05 |
Atlanticus | ATLC | Nov 22, 2024 | 55.16 | +1.58 |
Atlanticus B Pref | ATLCP | Nov 22, 2024 | 23.77 | -0.49 |
Atlas Energy Solutions | AESI | Nov 22, 2024 | 23.59 | +9.67 |
Atlas Lithium | ATLX | Nov 22, 2024 | 7.93 | +2.06 |
Atlas Pref D | ATCO-D | Nov 22, 2024 | 25.19 | +0.49 |
Atlas Pref H | ATCO-H | Nov 22, 2024 | 25.07 | +0.38 |
AtlasClear Holdings | ATCH | Nov 22, 2024 | 0.22 | -5.46 |
Atlassian A | TEAM | Nov 22, 2024 | 260.58 | +2.60 |
Atmos Energy | ATO | Nov 22, 2024 | 150.05 | -0.14 |
Atmus Filtration Technologies | ATMU | Nov 22, 2024 | 44.50 | +1.67 |
ATN International | ATNI | Nov 22, 2024 | 20.28 | -0.10 |
Atomera | ATOM | Nov 22, 2024 | 5.80 | -0.26 |
Atossa Therapeutics | ATOS | Nov 22, 2024 | 1.22 | +2.52 |
Atour Lifestyle ADR | ATAT | Nov 22, 2024 | 25.27 | -0.32 |
ATRenew A ADR | RERE | Nov 22, 2024 | 2.83 | +1.07 |
AtriCure | ATRC | Nov 22, 2024 | 35.73 | +0.15 |
ATS Corporation | ATS | Nov 22, 2024 | 31.28 | +6.98 |
aTyr Pharma | ATYR | Nov 22, 2024 | 3.03 | +1.68 |
Auburn National Bank | AUBN | Nov 22, 2024 | 23.35 | -0.74 |
Auddia | AUUD | Nov 22, 2024 | 0.57 | +1.06 |
AudioCodes | AUDC | Nov 22, 2024 | 9.14 | +4.22 |
AudioEye | AEYE | Nov 22, 2024 | 27.23 | +7.88 |
Auna S.A.A | AUNA | Nov 22, 2024 | 7.06 | -0.84 |
Aura Biosciences | AURA | Nov 22, 2024 | 8.95 | -0.89 |
Aura FAT Projects Acquisition A | AFAR | Nov 22, 2024 | 11.68 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.